Cart
sales@molnova.com
CPA inhibitor
CAS No. 223532-02-3
CPA inhibitor( —— )
Catalog No. M32860 CAS No. 223532-02-3
CPA inhibitor (Carboxypeptidase inhibitor) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0.32 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 134 | In Stock |
|
| 5MG | 121 | In Stock |
|
| 10MG | 158 | In Stock |
|
| 25MG | 277 | In Stock |
|
| 50MG | 397 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPA inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPA inhibitor (Carboxypeptidase inhibitor) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0.32 μM.
-
DescriptionCPA inhibitor (Carboxypeptidaseinhibitor; compound 5) is a potent carboxypeptidase A (CPA) inhibitor with a Ki of 0.32 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCarboxypeptidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number223532-02-3
-
Formula Weight313.35
-
Molecular FormulaC18H19NO4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (319.13 mM; Ultrasonic )
-
SMILESON(CC(Cc1ccccc1)C(O)=O)C(=O)Cc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. D H Kim, et al. First hydroxamate inhibitors for carboxypeptidase A. N-acyl-N-hydroxy-beta-phenylalanines. Bioorg Med Chem Lett. 1999 Mar 8;9(5):691-6.?
molnova catalog
related products
-
Kinase Domain of Ins...
Kinase Domain of Insulin Receptor (2)
-
Fructosylvaline
Fructosylvaline（Fru-val） is present in miso, white wine and sake and has been associated with oxidative browning of white wine and sake.
-
Picrocrocin
Picrocrocin, an apocarotenoid found in the flowers of Cochliobolus sativus. Picrocrocin shows anticancer effect. Picrocrocin exhibits growth inhibitory effects against SKMEL-2 human malignant melanoma cells.
